Medicare Enrolled

Dr. C Chance, MD

Obstetrics & Gynecology · Augusta, GA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
1348 WALTON WAY, Augusta, GA 30901
7067221381
In practice since 2006 (19 years)
NPI: 1013022029 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Chance from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chance? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Chance

Dr. C Chance is an obstetrics & gynecology specialist in Augusta, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chance performed 2,967 Medicare services across 2,836 unique beneficiaries.

Between the years covered by Open Payments, Dr. Chance received a total of $11,516 from 51 pharmaceutical and/or device companies across 256 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in obstetrics & gynecology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Chance is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 1% volume in GA $11,516 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,967
Medicare services
Top 1% in GA for obstetrics & gynecology
2,836
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~156 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hemoglobin blood test
A blood test that measures the amount of hemoglobin, the protein in red blood cells that carries oxygen.
492 $2 $8
3D screening mammography (tomosynthesis)
A screening imaging test of the breast using 3D technology to detect potential abnormalities.
374 $50 $151
Screening mammography
An X-ray of the breast used to detect breast cancer in women who have no signs or symptoms of the disease.
374 $117 $336
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
311 $55 $124
Stool test for hidden blood (FIT)
A laboratory test that analyzes a stool sample to detect hidden blood using an immunoassay method.
301 $16 $50
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
253 $83 $181
Bone density scan (DEXA)
A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures.
207 $35 $379
Pelvic and clinical breast exam for cancer screening
A physical examination of the pelvis and breasts to screen for cervical or vaginal cancer. This procedure involves a clinical assessment performed by a healthcare provider.
190 $37 $62
Pap smear screening test
A screening test to collect and prepare a cervical or vaginal sample for laboratory analysis.
183 $40 $72
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
108 $9 $60
Complete breast ultrasound, 1 breast
A complete ultrasound examination of one breast to visualize internal structures.
65 $103 $557
Fecal immunochemical test (FIT), 1-3 simultaneous
A screening test that uses a stool sample to detect hidden blood in the feces, helping to identify potential colorectal cancer.
53 $17 $50
Transvaginal pelvic ultrasound
An ultrasound exam using a probe inserted into the vagina to image the uterus, ovaries, fallopian tubes, cervix, and surrounding pelvic structures.
29 $76 $309
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
27 $68 $171
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$11,516
Total received (2018-2024)
Avg $1,645/year across 7 years
Top 3% in GA for obstetrics & gynecology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
256
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,657 (57.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,859 (42.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$696
2023
$1,419
2022
$4,297
2021
$3,645
2020
$160
2019
$653
2018
$646

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$217
Astellas Pharma US Inc
$173
Axonics, Inc.
$86
ABBVIE INC.
$51
Exeltis, USA Inc.
$35
Exact Sciences Corporation
$30
Medtronic, Inc.
$30
PFIZER INC.
$24
Amgen Inc.
$17
Aspira Women's Health Inc
$17
Organon Llc
$10
Channel Medsystems, Inc.
$5
Top 3 companies account for 68.4% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$6,459
Novo Nordisk Inc
$578
Boston Scientific Corporation
$478
ABBVIE INC.
$466
AbbVie Inc.
$448
Astellas Pharma US Inc
$436
Axonics, Inc.
$292
AMAG Pharmaceuticals, Inc.
$276
Exeltis, USA Inc.
$187
AbbVie, Inc.
$173
PFIZER INC.
$170
TherapeuticsMD, Inc.
$138
Bayer HealthCare Pharmaceuticals Inc.
$121
Medtronic, Inc.
$114
Aspira Women's Health Inc
$97
Duchesnay USA Incorporated
$75
MAYNE PHARMA INC.
$71
Roche Diagnostics Corporation
$64
Amgen Inc.
$63
Hologic Sales and Service, LLC
$62
Allergan Inc.
$54
Nalpropion Pharmaceuticals, Inc.
$47
Currax Pharmaceuticals LLC
$44
Agile Therapeutics, Inc.
$42
Bayer Healthcare Pharmaceuticals Inc.
$41
Ethicon US, LLC
$33
Applied Medical Resources Corporation
$32
Myovant Sciences Inc.
$32
Exact Sciences Corporation
$30
IDORSIA PHARMACEUTICALS US INC
$30
Hologic, LLC
$27
Nalpropion Pharmaceuticals LLC
$27
EAGLE PHARMACEUTICALS, INC.
$25
Merck Sharp & Dohme Corporation
$23
Richard Wolf Medical Instruments Corp.
$23
Sumitomo Pharma America, Inc.
$23
Shield Therapeutics Inc
$23
Mallinckrodt LLC
$23
CooperSurgical, Inc.
$19
Synergy Pharmaceuticals Inc
$16
VIVUS, Inc.
$15
KVK-Tech, Inc.
$14
Lupin Inc.
$14
Takeda Pharmaceuticals U.S.A., Inc.
$14
Pacira Pharmaceuticals Incorporated
$13
Orexigen Therapeutics, Inc.
$13
Avion Pharmaceuticals
$12
Eisai Inc.
$12
Allergan, Inc.
$12
Organon Llc
$10
Channel Medsystems, Inc.
$5
Top 3 companies account for 65.3% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ANNOVERA · APTIMA · Axonics · BARHEMSYS · BOTOX · Balcoltra · Belviq · CONTRAVE · Cologuard Collection Kit · DAVINCI XI · Da Vinci Surgical System · EVENITY · EXPAREL · Endosee · Enseal · Fluent · IMVEXXY · INTRAROSA · Kyleena · LILETTA · LO LOESTRIN FE · Lupron · MAKENA · MYFEMBREE · MYRBETRIQ · Mirena · Myrbetriq · NEXPLANON · NOVASURE · OFIRMEV · ORIAHNN · ORILISSA · OVA1 · Orilissa · Osphena · PLASMABLADE(TM) · PREMARIN · PREMARIN ORALS · Prolia · QSYMIA · QULIPTA · QUVIVIQ · RS Harmony Test Related Products · SLYND · SOLOSEC · SURGICEL Family of Absorbable Hemostats · Saxenda · Solyx SIS System · TRINTELLIX · TRUCLEAR · Trulance · Twirla · UBRELVY · Veozah · Wegovy
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (58%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in obstetrics & gynecology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 3% for obstetrics & gynecology in GA.

Looking for an obstetrics & gynecology specialist in Augusta?
Compare obstetricians & gynecologists in the Augusta area by procedure volume, costs, and industry payment transparency.
Browse obstetricians & gynecologists nearby

Geographic Context

Obstetricians & gynecologists within 10 mi
107
Per 100K population
51.9
County median income
$53,197
Nearest hospital
PIEDMONT AUGUSTA HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Chance is a clinical cardiology specialist, with above-average Medicare volume (top 1% in GA), with speaking/promotional industry engagement in the top 3% of GA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Chance experienced with hemoglobin blood test?
Based on Medicare claims data, Dr. Chance performed 492 hemoglobin blood test services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chance receive payments from pharmaceutical companies?
Yes. Dr. Chance received a total of $11,516 from 51 companies across 256 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chance's costs compare to other obstetricians & gynecologists in Augusta?
Dr. Chance's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chance) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →